Manica Balasegaram
Dr. Manica Balasegaram is the executive director of the Global Antibiotic Research and Development Partnership and has been instrumental in the development and clinical trials of new treatments for gonorrhea, emphasizing the importance of accessible treatment amid rising drug resistance.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 9.00 | 0.04% | +0% | 331,002,651 | 148,033 | $21,000,000 | 9,392$ |
| Totals | 1 | 331,002,651 | 148,033 | $21,000,000 | 9,392$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Dr. Manica Balasegaram, executive director of the Global Antibiotic Research and Development Partnership, highlighted the advantages of the new treatment options.
9
United Kingdom:
Dr Manica Balasegaram is executive director of the Global Antibiotic Research and Development Partnership.
8